Thermo Fisher Scientific (TMO) reported Q1 adjusted earnings Wednesday of $5.15 per diluted share, up from $5.11 a year earlier.
Analysts polled by FactSet expected $5.10.
Revenue for the quarter ended March 29 was $10.36 billion, up from $10.35 billion a year earlier.
Analysts surveyed by FactSet expected $10.23 billion.
The company's shares were up 2.9% in recent premarket activity.